Can-Fite BioPharma American Depositary Shares
CANF
9 hedge funds and large institutions have $3.2M invested in Can-Fite BioPharma American Depositary Shares in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
275% more capital invested
Capital invested by funds: $854K → $3.2M (+$2.35M)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
80% more funds holding
Funds holding: 5 → 9 (+4)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$322K |
| 2 |
TAM
Taylor Asset Management
Toronto,
Ontario, Canada
|
+$309K |
| 3 |
Morgan Stanley
New York
|
+$188K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$33.6K |
| 5 |
BG
Bollard Group
Boston,
Massachusetts
|
+$20.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$13.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11K |
| 3 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
-$6.71K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $2.01M | +$309K | +46 | +40% |
|
|
2
Jane Street
New York
| $592K | +$322K | +48 | New |
|
|
3
Morgan Stanley
New York
| $347K | +$188K | +28 | New |
|
|
VKH
4
Virtu KCG Holdings
New York
| $61K | -$13.4K | -2 | -29% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $58K | +$33.6K | +5 | New |
|
|
MC
6
Menta Capital
San Francisco,
California
| $51K | – | – | – |
|
|
BG
7
Bollard Group
Boston,
Massachusetts
| $32K | +$20.1K | +3 | New |
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| $25K | +$13.4K | +2 | New |
|
9
Citigroup
New York
| $16K | +$6.71K | +1 | New |
|
|
MFS
10
MSI Financial Services
Springfield,
Massachusetts
| $4K | -$6.71K | -1 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$11K | -2 | Closed |
|
CANF Hedge Fund Activity: Q3 2015 in Review
9 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q3 2015, worth a combined $3.2M — up 275% from $854K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CANF positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $322K. The largest seller was Virtu KCG Holdings, cutting an estimated $13.4K.
- 9 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q3 2015, up from 5 in Q2 2015.
- Funds reported $3.2M of Can-Fite BioPharma American Depositary Shares stock for Q3 2015, up 275% quarter-over-quarter.
- 6 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q3 2015 and 2 closed out, a net change of +4 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q3 2015 was Jane Street, an estimated $322K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q3 2015 was Virtu KCG Holdings, an estimated $13.4K sold.
Based on aggregated 13F filings for Q3 2015.